Birchview Capital, LP Scholar Rock Holding Corp Transaction History
Birchview Capital, LP
- $111 Million
- Q1 2025
A detailed history of Birchview Capital, LP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Birchview Capital, LP holds 16,000 shares of SRRK stock, worth $511,360. This represents 0.46% of its overall portfolio holdings.
Number of Shares
16,000
Previous 8,000
100.0%
Holding current value
$511,360
Previous $345,000
48.99%
% of portfolio
0.46%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding SRRK
# of Institutions
251Shares Held
90.5MCall Options Held
706KPut Options Held
456K-
Siren, L.L.C. New York, NY9.25MShares$296 Million16.93% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.89MShares$284 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$181 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA5.61MShares$179 Million83.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.85MShares$155 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.65B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...